QA: MyoKardia Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001552451_2020_MyoKardia_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001552451')"}

Graph

Absolute values for 0001552451, MyoKardia Inc.

  xvar xval
0 AssetsCurrent 423,836,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 15,743,000
3 remainder_Assets 16,515,000
4 LiabilitiesCurrent 47,912,000
5 LiabilitiesNoncurrent 1,908,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 61,663,000
9 ResearchAndDevelopmentExpense 146,171,000
10 remainder_Expenses 80,000,000
11 remainder_Revenues 0
12 remainder_NetIncome 11,621,000
13 remainder_ComprehensiveNetIncome 616,000
  yvar yval
0 Assets 456,094,000
1 Liabilities 49,820,000
2 Expenses 287,834,000
3 Revenues 0
4 StockholdersEquity 406,274,000
5 NetIncome -276,213,000
6 ComprehensiveNetIncome -275,905,000
7 BaseVar 402,992,500
8 EconomicCapitalRatio 1.67

Edgar->Model Mapping

Feature Distribution

Change over Time